Literature DB >> 18565847

The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?

Paul M Ridker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18565847     DOI： 10.1161/ATVBAHA.108.168989

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic options to further lower C-reactive protein for patients on statin treatment.

Authors:  Parag H Joshi; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

2.  Atherosclerosis: A Link Between Lipid Intake and Protein Tyrosine Nitration.

Authors:  Rita K Upmacis
Journal:  Lipid Insights       Date:  2008-11-11

Review 3.  Novel immune signals and atherosclerosis.

Authors:  Hiroshi Iwata; Ryozo Nagai
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 4.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

5.  Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective.

Authors:  Mario Di Napoli; Imtiaz M Shah
Journal:  J Aging Res       Date:  2011-10-31

Review 6.  Molecular pathways regulating macrophage polarization: implications for atherosclerosis.

Authors:  Marten A Hoeksema; J Lauran Stöger; Menno P J de Winther
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.